Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $3.71B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 102 | $3.70B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 103 | $3.67B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 104 | $3.63B | Healthcare | Healthcare Providers | United States | NYSE |
| 105 | $3.56B | Healthcare | Medical Devices | United States | Nasdaq |
| 106 | $3.44B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 107 | $3.42B | Healthcare | Medical Devices | United States | NYSE |
| 108 | $3.40B | Healthcare | Health Services | United States | NYSE |
| 109 | $3.38B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 110 | $3.31B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 111 | $3.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $3.17B | Healthcare | Medical Devices | United States | Nasdaq |
| 113 | $3.14B | Healthcare | Biotechnology | United States | Nasdaq |
| 114 | $3.01B | Healthcare | Healthcare Providers | United States | NYSE |
| 115 | $2.99B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $2.95B | Healthcare | Biotechnology | United States | Nasdaq |
| 117 | $2.86B | Healthcare | Medical Devices | United States | Nasdaq |
| 118 | $2.84B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 119 | $2.76B | Healthcare | Healthcare Providers | United States | NYSE |
| 120 | $2.71B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 121 | $2.66B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 122 | $2.65B | Healthcare | Biotechnology | United States | Nasdaq |
| 123 | $2.64B | Healthcare | Medical Devices | United States | Nasdaq |
| 124 | $2.60B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 125 | $2.59B | Healthcare | Biotechnology | United States | Nasdaq |
| 126 | $2.58B | Healthcare | Biotechnology | United States | Nasdaq |
| 127 | $2.49B | Healthcare | Biotechnology | United States | Nasdaq |
| 128 | $2.41B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 129 | $2.37B | Healthcare | Medical Devices | United States | NYSE |
| 130 | $2.30B | Healthcare | Medical Devices | United States | NYSE |
| 131 | $2.19B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $2.18B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 133 | $2.18B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 134 | $2.14B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $2.11B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 136 | $2.11B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 137 | $2.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 138 | $2.07B | Healthcare | Healthcare Providers | United States | NYSE |
| 139 | $2.06B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 140 | $1.98B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 141 | $1.97B | Healthcare | Medical Devices | United States | NYSE |
| 142 | $1.92B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 143 | $1.91B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 144 | $1.89B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 145 | $1.83B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 146 | $1.81B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 147 | $1.70B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 148 | $1.65B | Healthcare | Biotechnology | United States | Nasdaq |
| 149 | $1.64B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 150 | $1.59B | Healthcare | Healthcare Providers | United States | NYSE |
| 151 | $1.54B | Healthcare | Healthcare Providers | United States | NYSE |
| 152 | $1.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $1.50B | Healthcare | Biotechnology | United States | Nasdaq |
| 154 | $1.49B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 155 | $1.49B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 156 | $1.46B | Healthcare | Medical Devices | United States | Nasdaq |
| 157 | $1.46B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 158 | $1.43B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $1.43B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 160 | $1.39B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 161 | $1.37B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $1.31B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $1.30B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 164 | $1.27B | Healthcare | Medical Devices | United States | Nasdaq |
| 165 | $1.26B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 166 | $1.25B | Healthcare | Healthcare Providers | United States | NYSE |
| 167 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 169 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $1.23B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 171 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $1.21B | Healthcare | Biotechnology | United States | Nasdaq |
| 173 | $1.21B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 174 | $1.21B | Healthcare | Biotechnology | United States | Nasdaq |
| 175 | $1.21B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 176 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 177 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 178 | $1.15B | Healthcare | Medical Devices | United States | Nasdaq |
| 179 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 180 | $1.12B | Healthcare | Pharmaceuticals | United States | NYSE |
| 181 | $1.11B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 182 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 183 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 184 | $1.09B | Healthcare | Medical Devices | United States | Nasdaq |
| 185 | $1.09B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 186 | $1.09B | Healthcare | Biotechnology | United States | Nasdaq |
| 187 | $1.07B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $1.07B | Healthcare | Medical Devices | United States | NYSE |
| 189 | $1.04B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 190 | $1.03B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 191 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 192 | $998.17M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 193 | $994.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 194 | $985.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $967.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 196 | $955.58M | Healthcare | Biotechnology | United States | Nasdaq |
| 197 | $925.99M | Healthcare | Medical Devices | United States | NYSE |
| 198 | $920.52M | Healthcare | Medical Devices | United States | NYSE |
| 199 | $917.90M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 200 | $917.30M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
U.S.-exchange common stocks; ADRs and funds excluded. 750 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.